Kashiv BioSciences to Be Acquired by Amneal Pharmaceuticals
MM Desk
25 April, 2026
Kashiv BioSciences has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals (NASDAQ:
Kashiv BioSciences has entered into a definitive agreement to be acquired by Amneal Pharmaceuticals (NASDAQ:
Amneal Pharmaceuticals announced on Tuesday its plan to invest up to USD 200 million (approximately